Description
Technical & Manufacturing Relevance:
Widely used for management of inflammation, joint and musculoskeletal health, osteoarthritis, rheumatoid support, gut inflammation, and respiratory wellness. Boswellic acids inhibit 5-lipoxygenase (5-LOX) pathway without typical NSAID gastric side effects. Poor water solubility—bioavailability-enhanced forms (AKBA-enriched, phospholipid complexes, micronized extracts) are preferred for consistent efficacy.
Applicable Dosage Forms:
Capsules, tablets, powders, sachets, softgels (enhanced absorption systems), polyherbal anti-inflammatory formulations
Pharmacopoeial / Quality Notes:
Assay of boswellic acids/AKBA by HPLC; control of residual solvents, heavy metals, pesticide residues, and microbial limits as per USP/Ph. Eur./WHO guidelines. Standardization percentage must be clearly declared on CoA.
Animal-origin Declaration:
100% plant-derived; vegan and non-animal origin
Manufacturing Support:
Available for contract manufacturing, private/white labeling, customized formulations (joint care, inflammation, gut & respiratory blends), complete regulatory documentation (CoA, MSDS, specifications), and export-ready compliance for resale and distribution worldwide
